Literature DB >> 28398477

Elective embryo transfers on Day 6 reduce implantation compared with transfers on Day 5.

V Poulsen1, H J Ingerslev1,2, K Kirkegaard3.   

Abstract

STUDY QUESTION: Is there a difference in pregnancy rates between embryos transferred electively on Day 5 and Day 6, respectively? SUMMARY ANSWER: The chance of pregnancy is significantly reduced (odds ratio (OR): 0.34; 95% CI 0.22-0.52) if transfer is performed on Day 6 compared with Day 5. WHAT IS KNOWN ALREADY: Several studies report that Day 5 transfers have higher implantation rates (IRs) when compared with Day 6 transfers. These studies were based on non-elective Day 6 transfers, where transfers on Day 6 were performed with developmentally delayed embryos. Traditionally, difference in IRs has therefore been explained by an impaired embryo quality. An alternative explanation is that endometrial receptivity is higher on Day 5 compared with Day 6. STUDY DESIGN, SIZE, DURATION: The study was conducted as a retrospective cohort follow-up study on single blastocyst transfers from February 2011 until August 2015 in patients aged <38 years, with ≥eight oocytes retrieved and no diagnosis of endometriosis. Non-elective Day 6 transfers were excluded. Post hoc power-calculations (two-sided level of significance 0.05, power of 0.80) indicate that 91 embryos were needed in each group to detect a reduction in IR (primary outcome) from 40 to 20%. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Day 5 or Day 6 transfers were implemented accordingly: from 2011 till 2013, transfers were performed on Day 6. If Day 6 was a Sunday, patients received Day 5 transfers. From 2013 onward, blastocysts were transferred on Day 5. If Day 5 was a Sunday, the transfer was delayed to Day 6. Univariable logistic regression analysis was performed to identify potential confounders. Factors with a P-value <0.1 were included in the multivariable logistic regression analysis. MAIN RESULTS AND THE ROLE OF CHANCE: We included 334 single elective Day 5 and 268 elective Day 6 transfers. The unadjusted odds for implantation between Day 5 and Day 6 groups were 0.35 (95% CI 0.25-0.49). A univariable logistic regression analysis identified maternal age, BMI, cumulative FSH dose, number of cryopreserved embryos, score of inner cell mass and trophectoderm and day of transfer as predictors of clinical pregnancy. When adjusting for these variables in a multivariable logistic regression analysis, the implantation odds for Day 5 transfer remained significantly higher than Day 6 (OR 0.34; 95% CI 0.22-0.52). LIMITATIONS, REASONS FOR CAUTION: The study was conducted on good prognosis patients. The majority of Day 6 transfers were performed in the beginning of the study period. Day 5 transfers were generally performed in the end of the study period. This difference in time of recruitment may cause a minor variation in the data but a subanalysis indicates that this potential variation is negligible. Day 5 scores were higher in the Day 5 transfer group. WIDER IMPLICATIONS OF THE
FINDINGS: Based on the findings in this study, transfers should be performed on Day 5. If Day 5 transfers are logistically impossible to perform, it is be preferable to cryopreserve the blastocyst and transfer in another cycle on Day 5, as Day 6 transfers should be avoided. STUDY FUNDING/COMPETING INTEREST(S): None.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  IVF; blastocyst; elective single embryo transfer; extended culture; implantation rate

Mesh:

Year:  2017        PMID: 28398477     DOI: 10.1093/humrep/dex059

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Increased live births after day 5 versus day 6 transfers of vitrified-warmed blastocysts.

Authors:  Alice Tubbing; Chloë Shaw-Jackson; Lieveke Ameye; Jérôme Colin; Serge Rozenberg; Candice Autin
Journal:  J Assist Reprod Genet       Date:  2017-12-04       Impact factor: 3.412

2.  Day 5 versus Day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes.

Authors:  Mathilde Bourdon; Khaled Pocate-Cheriet; Astri Finet de Bantel; Veronika Grzegorczyk-Martin; Aureli Amar Hoffet; Elisangela Arbo; Marine Poulain; Pietro Santulli
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.918

3.  The Influence of Delayed Blastocyst Development on the Outcome of Frozen-Thawed Transfer of Euploid and Untested Embryos.

Authors:  Parnita Sardana; Jwal Banker; Reena Gupta; Aditi Kotdawala; P G L Lalitkumar; Manish Banker
Journal:  J Hum Reprod Sci       Date:  2020-07-09

4.  Day 5 vitrified blastocyst transfer versus day 6 vitrified blastocyst transfer in oocyte donation program.

Authors:  G M Yerushalmi; T Shavit; S Avraham; M Youngster; A Kedem; I Gat; U S Dorofeyeva; S Mashiach; E Schiff; A Shulman; D S Seidman; A Wiser; E Maman; A Hourvitz; M Baum
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

5.  Embryo quality, ploidy, and transfer outcomes in male versus female blastocysts.

Authors:  Christopher P Moutos; William G Kearns; Sarah E Farmer; Jon P Richards; Antonio F Saad; John R Crochet
Journal:  J Assist Reprod Genet       Date:  2021-06-04       Impact factor: 3.357

6.  Marginal differences in preimplantation morphokinetics between conventional IVF and ICSI in patients with preimplantation genetic testing for aneuploidy (PGT-A): A sibling oocyte study.

Authors:  Neelke De Munck; Aşina Bayram; Ibrahim Elkhatib; Andrea Abdala; Ahmed El-Damen; Ana Arnanz; Laura Melado; Barbara Lawrenz; Human Mousavi Fatemi
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.752

7.  D6 blastocyst transfer on day 6 in frozen-thawed cycles should be avoided: a retrospective cohort study.

Authors:  Huiling Xu; Shumin Qiu; Xiaojing Chen; Suqin Zhu; Yan Sun; Beihong Zheng
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-07       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.